Undetectable Levels of CSF Amyloid-β Peptide in a Patient with 17β-Hydroxysteroid Dehydrogenase Deficiency

• Autor(a) principal: Ortez, C
• Data de Publicação: 2011
• Outros Autores: Villar, C, Fons, C, Duarte, ST, Pérez, A, García-Villoria, J, Ribes, A, Ormazábal, A, Casado, M, Campistol, Jaume, Vilaseca, MA, García-Cazorla, A
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.17/2499
• topic: 17-Hydroxysteroid Dehydrogenases; Amyloid beta-Peptides; Biomarkers; Brain Diseases, Metabolic, Inborn; Child, Preschool; Fatal Outcome; Genes, X-Linked; Humans; Male; HDE NEU PED

17β-hydroxysteroid dehydrogenase 10 (HSD10) deficiency is a rare X-linked inborn error of isoleucine catabolism. Although this protein has been genetically implicated in Alzheimer's disease pathogenesis, studies of amyloid-β peptide (Aβ) in patients with HSD10 deficiency have not been previously reported. We found, in a severely affected child with HSD10 deficiency, undetectable levels of Aβ in the cerebrospinal fluid, together with low expression of brain-derived neurotrophic factor, α-synuclein, and serotonin metabolites. Confirmation of these findings in other patients would help elucidating mechanisms of synaptic dysfunction in this disease, and highlight the role of Aβ in both early and late periods of life.